Noemí Malgrat González

Where does pharma really sit today on the AI and digital maturity curve, and how does this differ across commercial, field and marketing functions?
Who is moving beyond GenAI into deep, operational AI, and what does day-to-day AI usage look like in practice?
Where is AI delivering real commercial and engagement ROI today, and what can be learned from initiatives that failed?
How do pharma companies implement digital solutions without risk of compliance breaches or a loss of competitive edge?
Why has pharma's AI and digital journey lagged behind other industries, and how can you accelerate progress despite regulatory constraints?

Day 1 | 20th October